The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update
Clinical & Manufacturing

4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update

JUN 7, 2021
Seres Therapeutics Announces FDA Clearance of IND for Investigational Microbiome Therapeutic for the Prevention of Antibiotic-Resistant Bacterial Infections and GvHD
Finance

Seres Therapeutics Announces FDA Clearance of IND for Investigational Microbiome Therapeutic for the Prevention of Antibiotic-Resistant Bacterial Infections and GvHD

JUN 4, 2021
Global microbiome study discovers thousands of new species, maps urban antimicrobial resistance and reveals new drug candidates
Infectious Disease & AMR

Global microbiome study discovers thousands of new species, maps urban antimicrobial resistance and reveals new drug candidates

JUN 3, 2021
Bacthera Receives Manufacturing Licenses in Switzerland and Denmark
Bacthera

Bacthera Receives Manufacturing Licenses in Switzerland and Denmark

MAY 31, 2021
COVID-19 brings further evidence on the importance of microbes for our health
Finance

COVID-19 brings further evidence on the importance of microbes for our health

MAY 28, 2021
Ferring and Rebiotix Present Landmark Phase 3 Data
Clinical & Manufacturing

Ferring and Rebiotix Present Landmark Phase 3 Data

MAY 24, 2021
International organization honors renowned Rutgers microbiologist
Pharma & Human Health

International organization honors renowned Rutgers microbiologist

MAY 18, 2021
Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing
Finance

Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing

MAY 13, 2021
The surprising evolutionary history of our oral bacteria
Editor's Choice

The surprising evolutionary history of our oral bacteria

MAY 12, 2021
Research reveals ancient people had more diverse gut microorganisms
Pharma & Human Health

Research reveals ancient people had more diverse gut microorganisms

MAY 12, 2021
Chr. Hansen and Nestlé settle court case about Human Milk Oligosaccharides patent infringements
Finance

Chr. Hansen and Nestlé settle court case about Human Milk Oligosaccharides patent infringements

MAY 12, 2021